Equillium

EQNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$133.408 M

$2.11 -0.47%

Close of 7 Aug 2026

Revenue

$41.1M

#2803 by revenue

Earnings

-$22.4M

Loss-making

Shares outstanding

63,226,556

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#290Connect BiopharmaCNTB$138.8M
#291TuHURA BiosciencesHURA$135.6M
#292EquilliumEQ$133.4M
#293InflaRxIFRX$133.0M
#294ProMIS NeurosciencesPMN$131.9M

Where these numbers come from

Share counts and financials for Equillium are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.